SCHEMBL21986902

SCHEMBL21986902

CC(=O)C=Cc1ccc(C)c(O)c1

nearest known ligand 0.73

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IAPP P10997 3/20 0.73
PTGS1 P23219 1/20 0.73
APP P05067 3/20 0.58
TTR P02766 3/20 0.50
KDM4E B2RXH2 2/20 0.50
GLA P06280 2/20 0.50
HSD17B10 Q99714 2/20 0.50
TDP1 Q9NUW8 2/20 0.50
DPP4 P27487 2/20 0.50
BACE1 P56817 2/20 0.50
MMP1 P03956 2/20 0.50
MMP2 P08253 2/20 0.50
MMP9 P14780 2/20 0.50
PTPN1 P18031 2/20 0.50
MAPT P10636 2/20 0.50
MEN1 O00255 1/20 0.50
HDAC3 O15379 1/20 0.50
CA12 O43570 1/20 0.50
AKR1B10 O60218 1/20 0.50
ALDH1A1 P00352 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21986720 1.00 IAPP (0.73) IAPPPTGS1APPTTRKDM4E
SCHEMBL14472602 0.85 KDM4E (0.70) IAPPPTGS1APPTTRKDM4E
SCHEMBL12220501 0.85 IAPP (0.73) IAPPPTGS1APPTTRKDM4E
SCHEMBL29364807 0.85 IAPP (1.00) IAPPPTGS1APPTTRKDM4E
SCHEMBL1881133 0.85 IAPP (1.00) IAPPPTGS1APPTTRKDM4E
SCHEMBL1881134 0.85 IAPP (1.00) IAPPPTGS1APPTTRKDM4E
SCHEMBL14926717 0.85 IAPP (0.61) IAPPPTGS1APPKDM4EGLA
SCHEMBL21986709 0.84 PELI1 (0.53) IAPPPTGS1APPTTRKDM4E
SCHEMBL30739974 0.84 PELI1 (0.53) IAPPPTGS1APPTTRKDM4E
SCHEMBL28055089 0.84 PELI1 (0.53) IAPPPTGS1APPTTRKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11629121-B2 Benzylideneacetone derivative and use thereof KORPHARM CO., LTD. (KR) 2023-04-18 US disclosed
US-20210139414-A1 NOVEL BENZYLIDENEACETONE DERIVATIVE AND USE THEREOF KORPHARM CO., LTD. (KR) 2021-05-13 US disclosed
EP-3659592-A1 NOVEL BENZYLIDENEACETONE DERIVATIVE AND USE THEREOF Korpharm Co., Ltd. (KR) 2020-06-03 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210139414-A1 NOVEL BENZYLIDENEACETONE DERIVATIVE AND USE THEREOF EBP, CREBBP, BPTF IAPP 2237/4885PTGS1 413/4885APP 1553/4885
US-11629121-B2 Benzylideneacetone derivative and use thereof GNPAT, NAT1, ALDH7A1 IAPP 2353/4885PTGS1 1063/4885APP 1648/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.